Prot# IM101-031-016: A Phase III, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Use Study to Evaluate the Safety and Tolerability of BMS-188667 Administered Intravenously to Subjects with Active RA with or without Medic

Project: Research project

Project Details

StatusFinished
Effective start/end date1/9/03 → 9/11/10

Funding

  • Bristol-Myers Squibb Pharmaceutical Research Institute (IM101-031-016)